Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data | Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Not yet recruiting | Not stated | 2025-01-01 | NCT06754865 | |
| Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2024-12-05 | NCT06574503 | |
| Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 3 | 2024-12-04 | NCT06573008 |